Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver Diseases and Immunity, Liver Disease and Transplantation, and Gallbladder and Bile Duct Disorders.
Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation
Mapping the landscape of biliary tract cancer in Europe: challenges and controversies
Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study
Oxidative stress in metabolic dysfunction‐associated steatotic liver disease ( <scp>MASLD</scp> ): How does the animal model resemble human disease?
Amendment „Neue Nomenklatur zur MASLD (Metabolic Dysfunction Associated Steatotic Liver Disease; metabolische Dysfunktion assoziierte steatotische Lebererkrankung)“ zur S2k-Leitlinie „Nicht-alkoholische Fettlebererkrankung“ (v.2.0/April 2022) der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)
Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease
ASO Visual Abstract: Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma
Liver Tests, Cardiovascular Outcomes and Effects of Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
Liver phenotypes in <scp>PCOS</scp>: Analysis of exogenous and inherited risk factors for liver injury in two European cohorts
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025
Genetic variation in <i>TERT</i> modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study
TNF-related apoptosis-inducing ligand, interferon gamma-induced protein 10, and C-reactive protein in predicting the progression of SARS-CoV-2 infection: a prospective cohort study
Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
Epithelia-Sensory Neuron Cross Talk Underlies Cholestatic Itch Induced by Lysophosphatidylcholine
Key summary of German national treatment guidance for hospitalized COVID-19 patients
Increased B‐cell activity with consumption of activated monocytes in severe COVID‐19 patients
Presentation, Management and Outcome of Cholangiocarcinoma in Europe: Results From Real-World Patient Registry
rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
Phenotyping non‐alcoholic fatty liver disease by the gut microbiota: Ready for prime time?
High Protein Intake Is Associated With Histological Disease Activity in Patients With NAFLD
Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis
Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centers